![Anti-CD274 [ARC61782] Monoclonal Antibody (CAB23922)](https://cdn11.bigcommerce.com/s-39x6lpnvxv/images/stencil/1280x1280/products/237937/281189/t-cell-exhaustion-and-checkpoints-antibody-sampler-pack__94694__56007.1786234156.jpg?c=1&imbypass=on "Anti-CD274 [ARC61782] Monoclonal Antibody (CAB23922)")
![Anti-CD274 [ARC61782] Monoclonal Antibody (CAB23922)](https://cdn11.bigcommerce.com/s-39x6lpnvxv/images/stencil/100x100/products/237937/281189/t-cell-exhaustion-and-checkpoints-antibody-sampler-pack__94694__56007.1786234156.jpg?c=1 "Anti-CD274 [ARC61782] Monoclonal Antibody (CAB23922)")
Description
T-Cell Exhaustion & Checkpoints Antibody Sampler Pack
The T-Cell Exhaustion & Checkpoints Antibody Sampler Pack from Assay Genie brings together 8 rigorously validated antibodies spanning the key nodes of this pathway, supplied in a convenient 20µL trial size. It lets researchers screen an entire signalling axis in a single, cost-effective pack — validated for applications including ELISA, IHC-P, WB — before committing to full-size vials. Each antibody is also available individually in a full 100µL size.
| Target | Antibody | Cat. No. | Host | Reactivity | Applications | Size |
| PD-1 | Anti-PD-1/CD279 Polyclonal Antibody -Knockout Validated | CAB5584-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
| PD-L1 | Anti-CD274 [ARC61782] Monoclonal Antibody | CAB23922-20 | Rabbit | Mouse | WBELISA | 20µL |
| CTLA-4 | Anti-CTLA4 Antibody | CAB2063-20 | Rabbit | Human, Mouse, Rat | WBIHC-PELISA | 20µL |
| VISTA / VSIR | Anti-VISTA / B7-H5 / GI24 Polyclonal Antibody | CAB24535-20 | Rabbit | Human Rat | WBIHC-PELISA | 20µL |
| TIM-3 | Anti-TIM-3/HAVCR2 Antibody | CAB13445-20 | Rabbit | Human, Mouse, Rat | WBIHC-PELISA | 20µL |
| CD96 | Anti-CD96 Polyclonal Antibody | CAB20547-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
| TCF1 / TCF7 | Anti-TCF7 Antibody | CAB3091-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
| EOMES | Anti-EOMES Polyclonal Antibody | CAB18222-20 | Rabbit | Human, Mouse, Rat | WBELISA | 20µL |
T-cell exhaustion is a distinct differentiation state that arises during chronic antigen exposure, as occurs in persistent viral infection and cancer, in which T cells progressively lose effector function, proliferative capacity, and cytokine production. This dysfunctional state is enforced by the sustained expression of inhibitory immune checkpoint receptors that counterbalance activating signals. PD-1 is the cardinal exhaustion marker; engagement by its ligand PD-L1, frequently upregulated on tumor cells and antigen-presenting cells, recruits phosphatases that dampen proximal TCR signaling. CTLA-4 acts earlier, outcompeting the costimulatory receptor CD28 for B7 ligands and raising the threshold for activation, while functioning prominently in regulatory T-cell-mediated suppression. Additional coinhibitory receptors define the depth of exhaustion and offer complementary therapeutic targets: VISTA/VSIR is a negative regulator highly expressed on myeloid cells and T cells, TIM-3 marks terminally exhausted cells and binds galectin-9 and other ligands, and CD96 competes with activating receptors for nectin ligands to restrain NK- and T-cell responses. The fate and reversibility of exhausted populations are governed by transcription factors. TCF1/TCF7 marks a stem-like, self-renewing progenitor pool that sustains the response and mediates the proliferative burst following checkpoint blockade, whereas the T-box factor EOMES is associated with the transition toward terminal differentiation and effector cytotoxic programs. Understanding the interplay between surface checkpoints and these transcriptional regulators is fundamental to cancer immunotherapy and to predicting and improving responses to checkpoint inhibitors. Characterizing these populations demands reagents that resolve both surface receptors and lineage-defining transcription factors. This sampler pack brings together validated antibodies against PD-1, PD-L1, CTLA-4, VISTA/VSIR, TIM-3, CD96, TCF1/TCF7, and EOMES for studying T-cell exhaustion and immune checkpoint regulation.
| Analyte | Alternate Names |
| PD-1 | PDCD1, PD-1, CD279, Programmed cell death protein 1 |
| PD-L1 | CD274, PD-L1, B7-H1, Programmed cell death 1 ligand 1, PDCD1LG1 |
| CTLA-4 | CTLA4, CD152, Cytotoxic T-lymphocyte associated protein 4 |
| VISTA / VSIR | VSIR, VISTA, B7-H5, PD-1H, GI24, C10orf54 |
| TIM-3 | HAVCR2, TIM-3, T-cell immunoglobulin and mucin domain 3, CD366 |
| CD96 | TACTILE, T-cell activation increased late expression |
| TCF1 / TCF7 | TCF7, TCF-1, Transcription factor 7, T-cell-specific transcription factor 1 |
| EOMES | Eomesodermin, T-box brain protein 2, TBR2 |
| Specification | Detail |
| Pack Format | 8 antibodies, 20µL each (trial size) |
| Storage | Store at -20°C upon receipt |
| Shelf Life | 12 months from date of receipt |
| Shipping | Gel pack |
| Scale-up | Every antibody is also available individually in a full 100µL size |
![Anti-CD28 [ARC5082-01] Monoclonal Antibody (CAB20346)](https://cdn11.bigcommerce.com/s-39x6lpnvxv/images/stencil/590x590/products/237938/281185/t-cell-activation-tcr-antibody-sampler-pack__85475__06329.1786234152.jpg?c=1 "Anti-CD28 [ARC5082-01] Monoclonal Antibody (CAB20346)")
![Anti-Cyclin E1 [ARC51383] Monoclonal Antibody (CAB22360)](https://cdn11.bigcommerce.com/s-39x6lpnvxv/images/stencil/590x590/products/237920/281032/cell-cycle-g1s-antibody-sampler-pack__32514__18898.1786234056.jpg?c=1 "Anti-Cyclin E1 [ARC51383] Monoclonal Antibody (CAB22360)")
![Anti-ENO2 [ARC52246] Monoclonal Antibody (CAB19091)](https://cdn11.bigcommerce.com/s-39x6lpnvxv/images/stencil/590x590/products/237949/281250/neuronal-and-glial-cell-type-id-antibody-sampler-pack__08328__98391.1786234214.jpg?c=1 "Anti-ENO2 [ARC52246] Monoclonal Antibody (CAB19091)")
